Back to results
US 2018/0002335 A1Published application
Treatment of cancers using pi3 kinase isoform modulators
AssigneeInfinity Pharmaceuticals, Inc.
InventorsHoward M. Stern, Jeffery L. Kutok
Life of this patent
Estimating the term…
Abstract
Provided herein are methods, kits, and pharmaceutical compositions that include a PI3 kinase inhibitor for treating cancers or hematologic disorders.
Claims9
1-41. (canceled)
A method for treating a hematologic malignancy selected from chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in a human patient comprising orally administering to the patient a compound, pharmaceutically acceptable salt, hydrate, co-crystal, clathrate or polymorph thereof in an amount of 25-75 mg twice a day, wherein the structure of the compound is:
Dependencies are inferred from the claim text.